Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women

Description:

Safety and immunogenicity Phase II study in 270 healthy pregnant women in Denmark and United Kingdom. Study is conducted under an IND.

Status:

Study is currently enrolling

Countries:

UK and Denmark

Clinicaltrials.gov